Evaluation of Safety and Efficacy of PDP-716

NCT03450629 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

682

Enrollment

INDUSTRY

Sponsor class

Conditions

Open Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Brimonidine Tartrate Ophthalmic Suspension
DRUG: Brimonidine Tartrate Ophthalmic Solution

Sponsor

Sun Pharma Advanced Research Company Limited